Today: 21 July 2026

Roman Perkowski

Roman Perkowski is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Cracow University of Economics, he previously worked in investment research and corporate finance. His coverage helps readers understand the key forces driving global financial markets and emerging industries. Follow Roman Perkowski on Google News.

AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

AbbVie said Monday it’s buying Apogee Therapeutics for $10.9 billion in cash, making this its largest deal since 2019. The company is looking to strengthen its immunology pipeline with Apogee’s long-acting immune-disease drugs. AbbVie and Apogee put out a joint release on the agreement, according to a securities filing. They expect the deal to close in the third quarter of 2026.
Intel (NASDAQ: INTC) Gets an Apple Premium, Math Shows Little Room Left

Intel (NASDAQ: INTC) Gets an Apple Premium, Math Shows Little Room Left

Intel Corporation is in focus Monday after jumping 10.64% to $133.99 last session. Early premarket quotes put the stock at $139.64, up 4.2% from that close. The gain comes after President Donald Trump said Apple would partner with Intel to design and make chips in the U.S. Reuters said Apple and Intel haven’t commented yet. For now, shares are trading up, with the deal details not out.
Walmart’s Hawaiian Roll Recall Linked to Wrapper, Not Bread

Walmart’s Hawaiian Roll Recall Linked to Wrapper, Not Bread

Walmart’s Great Value Hawaiian Roll four-packs are now included in a new FDA recall. United States Bakery, based in Oregon, reported an oily, sticky substance on the direct food-contact packaging. The recall covers 10,447 cases sent to 26 states. The concern centers on packaging that touches the rolls, not a confirmed problem with the bread itself.
22 June 2026
1 10 11 12 13 14 23

Stock Market Today

  • Berkshire Hathaway Leverages $397 Billion Cash Pile for Strategic Moves
    July 21, 2026, 3:59 PM EDT. Berkshire Hathaway (BRK.B) reported holding about $397.38 billion in cash reserves as of March 31, 2026, which includes $58.12 billion in cash and $339.26 billion in U.S. Treasury bills. This substantial liquidity allows the company to act on acquisitions, buy back shares, and meet capital requirements for subsidiaries. The reserve is bolstered by insurance float and consistent earnings, providing Berkshire a sustained edge even as BRK.B shares are down 2.5% YTD, trading at a price-to-book ratio of 1.45.
Go toTop